See more : E. I. du Pont de Nemours and Company (CTA-PB) Income Statement Analysis – Financial Results
Complete financial analysis of Yooma Wellness Inc. (LVVEF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Yooma Wellness Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Teva Pharmaceutical Industries Limited (TEVJF) Income Statement Analysis – Financial Results
- Innoviva, Inc. (INVA) Income Statement Analysis – Financial Results
- Danske Invest Nye Markeder Obligationer (DKINMOBL.CO) Income Statement Analysis – Financial Results
- Adcorp Holdings Limited (ADR.JO) Income Statement Analysis – Financial Results
- ZeroFox Holdings, Inc. (ZFOX) Income Statement Analysis – Financial Results
Yooma Wellness Inc. (LVVEF)
About Yooma Wellness Inc.
Yooma Wellness Inc. engages in the manufacturing, marketing, distribution, and sale of wellness products in Canada, the United States, Europe, and Asia. Its wellness products include hemp seed oil, and hemp-derived and cannabinoid (CBD) ingredients. The company sells its products through various platforms, such as ecommerce, mass-market retail, and independent retail partners. Yooma Wellness Inc. is headquartered in Toronto, Canada.
Metric | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|
Revenue | 0.00 | 10.18M | 34.79K | 152.01K |
Cost of Revenue | 0.00 | 7.81M | 292.50K | 263.71K |
Gross Profit | 0.00 | 2.37M | -257.71K | -111.70K |
Gross Profit Ratio | 0.00% | 23.30% | -740.67% | -73.48% |
Research & Development | 0.00 | 8.70K | 0.00 | 0.00 |
General & Administrative | 0.00 | 11.51M | 2.18M | 2.91M |
Selling & Marketing | 0.00 | 2.11M | 23.28K | 79.87K |
SG&A | 0.00 | 13.62M | 2.20M | 2.99M |
Other Expenses | 0.00 | 912.46K | 0.00 | 7.24K |
Operating Expenses | 0.00 | 14.55M | 2.20M | 2.99M |
Cost & Expenses | 0.00 | 22.36M | 2.50M | 3.26M |
Interest Income | 0.00 | 0.00 | 44.37K | 151.97K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 170.28K | 912.46K | 13.60K | 7.24K |
EBITDA | 0.00 | 10.05M | -1.74M | 1.90M |
EBITDA Ratio | 0.00% | 98.67% | -3,300.79% | 1,248.31% |
Operating Income | 0.00 | 9.14M | -1.15M | 1.89M |
Operating Income Ratio | 0.00% | 89.71% | -3,300.79% | 1,243.55% |
Total Other Income/Expenses | 0.00 | -33.33M | -1.78M | -8.10M |
Income Before Tax | 0.00 | -33.33M | -3.78M | -8.10M |
Income Before Tax Ratio | 0.00% | -327.28% | -10,850.39% | -5,330.66% |
Income Tax Expense | 0.00 | -214.90K | 1.31M | 5.20M |
Net Income | 0.00 | -33.12M | -5.09M | -13.30M |
Net Income Ratio | 0.00% | -325.17% | -14,625.18% | -8,752.00% |
EPS | 0.00 | -0.43 | -0.73 | -1.92 |
EPS Diluted | 0.00 | -0.43 | -0.73 | -1.92 |
Weighted Avg Shares Out | 0.00 | 77.55M | 6.98M | 6.91M |
Weighted Avg Shares Out (Dil) | 0.00 | 77.55M | 6.98M | 6.91M |
CSE Bulletin: Delist - Yooma Wellness Inc. (YOOM)
YOOMA WELLNESS ANNOUNCES BANKRUPTCY FILING
YOOMA WELLNESS INC. ANNOUNCES SALE OF VITALITY CBD
Yooma Wellness starting to see early positive results from streamlining efforts
Yooma Wellness continues to assess its strategic options
Yooma Wellness Reports Results for Q4 and Fiscal 2021, Exceeding Forecasts with Revenue of US$5.3M in Q4 2021
SEED Innovations says investee companies included on UK regulator CBD list
Yooma Wellness subsidiary added to CBD novel foods approved list
Yooma Wellness brands added to eBay CBD programme
Yooma Wellness looks to replicate success of management team in CBD and wellness market
Source: https://incomestatements.info
Category: Stock Reports